L'Oreal S.A. Unsponsored ADR (LRLCY)
L'Oreal sales slightly miss in fourth quarter as China weakness persists
French cosmetics giant L'Oreal on Thursday reported lower-than-expected fourth-quarter sales amid continued weakness in the Chinese beauty market and a slowdown in demand in the U.S. The world's largest beauty brand posted sales of 11.08 billion euros ($11.49 billion) in the three months to December, up 2.5% on a like-for-like basis and just shy of the 11.1 billion euros estimated.
L'Oréal to raise €3bn by selling block of shares back to Sanofi
L'Oréal will raise €3 billion by selling 29.6 million Sanofi shares back to Sanofi to cut its stake in the drugmaker. The French cosmetics giant, which also owns Garnier and Lancome, sold the shares back to Sanofi for €101.5 apiece as part of an effort to "optimize" its balance sheet after a recent acquisition spree.
L'Oréal: A Great Business For Long-Term Growth And Dividends, Cycle Perhaps Helps
L'Oréal's strong market presence, diverse brand portfolio, and consistent 12%+ long-term returns make it a resilient investment, even amid economic cycles like the China slowdown. The company's commitment to innovation, evidenced by increasing R&D expenses and 610 patents in 2023, ensures continued growth and market relevance. L'Oréal's robust sales organization, stable profit margins, and outstanding employee relations highlight its operational excellence and competitive edge in the beauty industry.
France's L'Oreal acquires Migros' South Korean cosmetic unit
French cosmetics giant L'Oreal said on Monday it had signed a deal with Swiss retailer Migros to buy the latter's South Korean skincare business Gowoonsesang Cosmetics, which includes the skin care brand Dr.G.
L'Oréal: China Weakness Opens Up An Attractive Entry Point (Rating Upgrade)
With its shares down sharply in recent months, cosmetics giant L'Oréal is looking at a fairly poor year on the shareholder returns front. Notwithstanding recent weakness in China, this remains an exceptional business worthy of a premium valuation. The stock now trades for around 28x EPS. I don't expect long-term multiple contraction from here, leaving investors clear to capture returns in line with EPS growth and the dividend.
L'Oreal in talks to buy Migros' South Korean cosmetic unit, sources say
French cosmetics giant L'Oreal is in final talks to acquire the South Korean skincare business Gowoonsesang Cosmetics owned by Mibelle Group, a unit of Swiss retailer Migros, according to two sources with knowledge of the deal.
L'Oreal results show China slump not done with luxury sector yet
China has been the go-to excuse for disappointing result after disappointing result in the global luxury sector for nigh on two years now, and L'Oreal's has not bucked the trend. Sales in the first nine months for France's third-largest company came to €32.4 billion, which was 6% higher on a yearly basis but considerably below analysts' expectations.
L'Oréal S.A. (LRLCF) 9-Month Sales Call Transcript
L'Oréal S.A. (OTCPK:LRLCF) 9-Month Sales Conference Call October 22, 2024 12:30 PM ET Corporate Participants Eva Quiroga - Head, Investor Relations Nicolas Hieronimus - Chief Executive Officer Christophe Babule - Chief Financial Officer Conference Call Participants Guillaume Delmas - UBS Iain Simpson - Barclays Olivier Nicolai - Goldman Sachs Sarah Simon - Morgan Stanley Jeff Stent - BNP Celine Pannuti - JPMorgan Charles Scotti - Kepler Chevreux James Edwardes Jones - RBC Tom Sykes - Deutsche Bank Rob Ottenstein - Evercore Operator Welcome to the conference call regarding L'Oréal 9-Month Sales.
L'Oreal reports 3.4% rise in third-quarter sales
French cosmetics giant L'Oreal reported a rise in third quarter sales on Tuesday that missed expectations, as it became the latest European company to see weaker-than-expected demand in China.
Pick L'Oréal Over Ulta Stock?
Given its better prospects, we believe that L'Oréal stock (OTCMKTS: LRLCY) is a better pick than its peer Ulta Beauty stock (NASDAQ: ULTA). LRLCY stock trades at a higher valuation multiple of 5.2x trailing revenues, versus 1.6x for ULTA stock.
L'Oreal: It Is Worth It To Buy This Beautiful Dividend Growth Stock
LRLCF, a premium consumer staple, has dropped considerably in share price, making it an intriguing investment opportunity due to its quality and defensive nature. The company has earnings stability, various competitive advantages, and is financially healthy. The fact that it also operates in a growing market makes it an excellent dividend growth investment candidate. LRLCF offers a safe dividend yield of 1.78% with a 10-year dividend growth CAGR of 10.2%, with growth likely to be sustained for years to come.
L'Oreal, Evonik join $38.6 mln funding round for biotech start-up Abolis
L'Oreal has joined Abolis Biotechnologies's 35 million euro ($38.6 million) funding round alongside speciality chemicals group Evonik , as part of a deal to develop bio-based ingredients for beauty products, the French cosmetics group said on Thursday.
